Association between statin use and colorectal cancer risk: a meta-analysis of 42 studies

[1] Edwards BK(2010)Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates Cancer 116 544-573

[2] Ward E(2013)Cancer statistics, 2013 CA Cancer J Clin 63 11-30

[3] Kohler BA(2004)Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging J Natl Cancer Inst 96 1420-1425

[4] Siegel R(2012)Chemoprevention in colorectal cancer—where we stand and what we have learned from twenty year’s experience Surgeon 10 43-52

[5] Naishadham D(2002)HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis Leukemia 16 508-519

[6] Jemal A(2008)Multi-target approaches in colon cancer chemoprevention based on systems biology of tumor cell-signaling Gene Regul Syst Bio 2 163-176

[7] O’Connell JB(2008)Combination of atorvastatin and celecoxib synergistically induces cell cycle arrest and apoptosis in colon cancer cells Int J Cancer 122 2115-2124

[8] Maggard MA(2000)3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study Arch Intern Med 160 2363-2368

[9] Ko CY(2004)The risk of cancer in users of statins J Clin Oncol 22 2388-2394

[10] Boghossian S(2004)Statin use and cancer risk in the general practice research database Br J Cancer 90 635-637

[1] Edwards BK(2010)Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates Cancer 116 544-573

[2] Ward E(2013)Cancer statistics, 2013 CA Cancer J Clin 63 11-30

[3] Kohler BA(2004)Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging J Natl Cancer Inst 96 1420-1425

[4] Siegel R(2012)Chemoprevention in colorectal cancer—where we stand and what we have learned from twenty year’s experience Surgeon 10 43-52

[5] Naishadham D(2002)HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis Leukemia 16 508-519

[6] Jemal A(2008)Multi-target approaches in colon cancer chemoprevention based on systems biology of tumor cell-signaling Gene Regul Syst Bio 2 163-176

[7] O’Connell JB(2008)Combination of atorvastatin and celecoxib synergistically induces cell cycle arrest and apoptosis in colon cancer cells Int J Cancer 122 2115-2124

[8] Maggard MA(2000)3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study Arch Intern Med 160 2363-2368

[9] Ko CY(2004)The risk of cancer in users of statins J Clin Oncol 22 2388-2394

[10] Boghossian S(2004)Statin use and cancer risk in the general practice research database Br J Cancer 90 635-637